Serveur d'exploration Chloroquine - Checkpoint (Istex)

Index « Teeft.i » - entrée « Rheumatoid arthritis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Rheumatoid arthriti < Rheumatoid arthritis < Rheumatoid arthritis activity  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 577.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000181 (2013) Yavuz Pehlivan [Turquie] ; Bunyamin Kisacik [Turquie] ; Vuslat Kecik Bosnak [Turquie] ; Ahmet Mesut Onat [Turquie]Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis
000187 (2013) Prabha Ranganathan [États-Unis]Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
000191 (2013) Jacques-Eric Gottenberg [France] ; Gael Cinquetti [France] ; Claire Larroche [France] ; Bernard Combe [France] ; Eric Hachulla [France] ; Olivier Meyer [France] ; Edouard Pertuiset [France] ; Guy Kaplanski [France] ; Laurent Chiche [France] ; Jean-Marie Berthelot [France] ; Bruno Gombert [France] ; Philippe Goupille [France] ; Christian Marcelli [France] ; Séverine Feuillet [France] ; Jean Leone [France] ; Jean Sibilia [France] ; Charles Zarnitsky [France] ; Philippe Carli [France] ; Stephanie Rist [France] ; Philippe Gaudin [France] ; Carine Salliot [France] ; Muriel Piperno ; Adeline Deplas [France] ; Maxime Breban [France] ; Thierry Lequerre [France] ; Pascal Richette [France] ; Charles Ghiringhelli [France] ; Mohamed Hamidou [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
000198 (2013) Inbal Braunstein [États-Unis] ; Victoria Werth [États-Unis]Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy
000228 (2013) Shweta Agarwal [Inde] ; Siddharth K. Das [Inde]Rheumatoid arthritis with increased bone mineral density
000242 (2013) E. R. Volkmann [États-Unis] ; S. Rezai [États-Unis] ; D. E. Furst [États-Unis] ; T. Woodworth [États-Unis]OP0153 The art of tapering glucocorticoids (GC): A systematic review of studies reporting tapering strategies and outcomes in patients with rheumatoid arthritis (RA)
000266 (2013) M. Nu Ez ; E. Nu Ez ; S. Sastre ; L. Lozano ; A. Saul ; C. Nicodemo [Espagne] ; J. M. Segur ; F. MaculéFRI0439 Beliefs, health status and outcomes in patients undergoing total knee arthroplasty. Prospective study with 12 months followup
000267 (2013) S. Kamali ; S. Pay ; N. Inanc ; I. Simsek ; V. Hamuryudan [Turquie]FRI0193 Current therapy of rheumatoid arthritis in turkey: rheumatologists’ perspective
000268 (2013) D. A. Pappas [États-Unis] ; M. Hooper ; G. Reed ; Y. Shan ; D. Wenkert ; J. Zhang [Royaume-Uni] ; J. Greenberg [États-Unis] ; J. Curtis [Royaume-Uni]FRI0108 Risk for herpes zoster after treatment with biologic and synthetic disease modifying agents for rheumatoid arthritis
000269 (2013) C. O. Bingham [États-Unis] ; W. Rizzo ; M. Klearman [États-Unis] ; A. Hassanali [États-Unis] ; R. Upmanyu [Royaume-Uni] ; A. Kivitz [États-Unis]FRI0106 Preliminary results from a controlled trial (VISARA) to evaluate the humoural immune response to vaccines in RA patients treated with tocilizumab (TCZ)
000270 (2013) B. Targonska-Stepniak [Pologne] ; M. Majdan [Pologne]FRI0105 Increased serum amyloid a (SAA) concentration in patients with rheumatoid arthritis as a marker of persistent inflammation and a risk of amyloidosis
000301 (2013) Abstracts
000306 (2013) S. G. Werner [Allemagne] ; F. Spiecker [Allemagne] ; O. Wiemann [Allemagne] ; S. Mettler [Allemagne] ; G. R. Burmester [Allemagne] ; M. Backhaus [Allemagne] ; H.-E. Langer [Allemagne]AB0754 Icg-enhanced fluorescence optical imaging detects typical inflammatory changes in asymptomatic subjects with elevated rheumatoid factor or anti-ccp antibodies
000307 (2013) J. P. C. Consignado ; C. Macapagal [Philippines] ; S. V. Navarra [Philippines]AB0374 End-organ damage in a cohort of filipino patients with systemic lupus erythematosus at two tertiary hospitals
000308 (2013) H. Gao [République populaire de Chine] ; J. He [République populaire de Chine] ; X.-W. Zhang [République populaire de Chine] ; M. Feng [République populaire de Chine] ; W. Zhao [République populaire de Chine] ; Y. Ding [République populaire de Chine] ; Z.-G. Li [République populaire de Chine]AB0373 Treatment of primary sjogren’s syndrome-associated lung disease: a prospective study
000309 (2013) G. Hakobyan ; V. Vardanyan [Arménie]AB0372 Safety of hydroxychloroquine in pregnant women with systemic lupus erythematosus and rheumatoid arthritis.
000310 (2013) G. Bertsias [Grèce] ; M. Mosca [Italie] ; A. Levitsky [Suède] ; R. F. Van Vollenhoven [Suède]AB0371 State of the art for treating-to-target in sle: a systematic literature review
000311 (2013) C. H. To [République populaire de Chine] ; L. Y. Ho [République populaire de Chine] ; K. L. Yu [République populaire de Chine] ; K. L. Chan [République populaire de Chine] ; P. T. Chan [République populaire de Chine] ; C. C. Mok [République populaire de Chine]AB0362 Tight control of disease activity by conventional DMARDs could minimize the use of biological therapies in patients with early rheumatoid arthritis: Data from an early arthritis clinic in hong kong
000313 (2013) Geoffrey Littlejohn [Australie, États-Unis] ; Lynden Roberts [Australie] ; Mark Arnold [Australie] ; Paul Bird [Australie] ; Simon Burnet [Australie] ; Julien De Jager [Australie] ; Hedley Griffiths [Australie] ; Dave Nicholls [Australie] ; James Scott [Australie] ; Jane Zochling [Australie] ; Kathleen E. Tymms [Australie]A multi‐center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control
000315 (2013) Atsuko Ashida [Japon] ; Hiroshi Murata [Japon] ; Atsuko Ohashi [Japon] ; Eisaku Ogawa [Japon] ; Hisashi Uhara [Japon] ; Ryuhei Okuyama [Japon]A case of hypocomplementaemic urticarial vasculitis with a high serum level of rheumatoid factor
000334 (2012) Haider M. Al Attia ; Mohamed AbushawishTreatment with tocilizumab leads to the disappearance of olecranon rheumatoid nodules

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Rheumatoid arthritis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Rheumatoid arthritis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Rheumatoid arthritis
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021